Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Foundation Medicine, Inc. (FMI) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Foundation Medicine, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1488613.
Total stock buying since 2014: $3,002,644,657.
Total stock sales since 2014: $326,017,462.
Total stock option exercises since 2014: $5,602,344.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2018 | 16,221,027 | $2,222,280,699 | 410,328 | $30,106,270 | 112,073 | $2,062,692 |
| 2017 | 0 | $0 | 480,792 | $20,284,903 | 147,290 | $1,824,430 |
| 2016 | 0 | $0 | 94,656 | $2,011,368 | 39,500 | $192,997 |
| 2015 | 15,613,388 | $780,363,958 | 4,945,563 | $239,794,705 | 411,317 | $1,375,740 |
| 2014 | 0 | $0 | 1,488,424 | $33,820,216 | 71,648 | $146,485 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2018-07 | 16,221,027 | $2,222,280,699 | 15,911 | $2,174,394 | 0 | $0 |
| 2018-06 | 0 | $0 | 3,500 | $369,075 | 0 | $0 |
| 2018-05 | 0 | $0 | 14,290 | $1,060,409 | 1,570 | $47,005 |
| 2018-04 | 0 | $0 | 44,302 | $3,257,088 | 2,344 | $16,689 |
| 2018-03 | 0 | $0 | 18,500 | $1,447,915 | 15,000 | $444,450 |
| 2018-02 | 0 | $0 | 186,534 | $13,434,217 | 40,630 | $920,017 |
| 2018-01 | 0 | $0 | 127,291 | $8,363,172 | 52,529 | $634,531 |
| 2017-12 | 0 | $0 | 134,146 | $8,155,493 | 27,500 | $102,232 |
| 2017-11 | 0 | $0 | 9,731 | $486,550 | 0 | $0 |
| 2017-10 | 0 | $0 | 25,766 | $1,026,478 | 0 | $0 |
| 2017-08 | 0 | $0 | 99,744 | $3,895,045 | 60,257 | $1,366,483 |
| 2017-07 | 0 | $0 | 75,906 | $2,958,288 | 0 | $0 |
| 2017-06 | 0 | $0 | 6,128 | $244,176 | 7,033 | $39,666 |
| 2017-05 | 0 | $0 | 1,009 | $34,174 | 0 | $0 |
| 2017-04 | 0 | $0 | 14,654 | $481,049 | 0 | $0 |
| 2017-03 | 0 | $0 | 59,272 | $1,979,038 | 52,500 | $316,049 |
| 2017-02 | 0 | $0 | 10,415 | $242,044 | 0 | $0 |
| 2017-01 | 0 | $0 | 44,021 | $782,568 | 0 | $0 |
| 2016-11 | 0 | $0 | 7,273 | $167,366 | 7,273 | $30,255 |
| 2016-10 | 0 | $0 | 15,524 | $363,434 | 0 | $0 |
| 2016-09 | 0 | $0 | 10,020 | $235,699 | 7,850 | $32,656 |
| 2016-08 | 0 | $0 | 23,863 | $573,272 | 24,377 | $130,086 |
| 2016-07 | 0 | $0 | 35,883 | $633,338 | 0 | $0 |
| 2016-06 | 0 | $0 | 472 | $10,223 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-07-31 | Roche Holding Ltd | Buy | 16,221,027 | 137.00 | 2,222,280,699 |
| 2018-07-02 | Fiedler Konstantin (Chief Operating Officer) | Sale | 994 | 136.66 | 135,840 |
| 2018-07-02 | Doherty Michael J (Head of Product Development) | Sale | 2,675 | 136.66 | 365,565 |
| 2018-07-02 | Nallicheri Melanie (Chief Business Officer) | Sale | 2,008 | 136.66 | 274,413 |
| 2018-07-02 | Cox Troy (Chief Executive Officer) | Sale | 1,402 | 136.66 | 191,597 |
| 2018-07-02 | Hesslein Robert W. (SVP and General Counsel) | Sale | 2,520 | 136.66 | 344,383 |
| 2018-07-02 | Ryan Jason (Chief Financial Officer) | Sale | 3,403 | 136.66 | 465,053 |
| 2018-07-02 | Miller Vincent A. (Chief Medical Officer) | Sale | 2,909 | 136.66 | 397,543 |
| 2018-06-15 | Pellini Michael J (Director) | Sale | 3,500 | 105.45 | 369,075 |
| 2018-05-21 | Miller Vincent A. (Chief Medical Officer) | Sale | 1,570 | 85.00 | 133,450 |
| 2018-05-21 | Miller Vincent A. (Chief Medical Officer) | Option Ex | 1,570 | 29.94 | 47,005 |
| 2018-05-16 | Cox Troy (Chief Executive Officer) | Sale | 2,157 | 77.10 | 166,304 |
| 2018-05-15 | Pellini Michael J (Director) | Sale | 3,500 | 76.05 | 266,175 |
| 2018-05-07 | Cox Troy (Chief Executive Officer) | Sale | 7,063 | 70.01 | 494,480 |
| 2018-04-16 | Ryan Jason (Chief Financial Officer) | Sale | 3,449 | 74.30 | 256,260 |
| 2018-04-16 | Miller Vincent A. (Chief Medical Officer) | Sale | 3,283 | 74.02 | 243,007 |
| 2018-04-16 | Pellini Michael J (Director) | Sale | 3,500 | 74.65 | 261,275 |
| 2018-04-03 | Doherty Michael J (Head of Product Development) | Sale | 2 | 72.40 | 144 |
| 2018-04-03 | Ryan Jason (Chief Financial Officer) | Sale | 1 | 72.40 | 72 |
| 2018-04-03 | Pellini Michael J (Director) | Sale | 13,659 | 70.28 | 959,954 |
| 2018-04-02 | Fiedler Konstantin (Chief Operating Officer) | Sale | 358 | 74.88 | 26,807 |
| 2018-04-02 | Doherty Michael J (Head of Product Development) | Sale | 8,190 | 74.87 | 613,185 |
| 2018-04-02 | Nallicheri Melanie (Chief Business Officer) | Sale | 1,253 | 74.88 | 93,824 |
| 2018-04-02 | Hesslein Robert W. (SVP and General Counsel) | Sale | 1,585 | 74.88 | 118,684 |
| 2018-04-02 | Hesslein Robert W. (SVP and General Counsel) | Option Ex | 2,344 | 7.12 | 16,689 |
| 2018-04-02 | Ryan Jason (Chief Financial Officer) | Sale | 6,139 | 76.21 | 467,853 |
| 2018-04-02 | Miller Vincent A. (Chief Medical Officer) | Sale | 2,883 | 74.93 | 216,023 |
| 2018-03-15 | Ryan Jason (Chief Financial Officer) | Sale | 15,000 | 78.26 | 1,173,900 |
| 2018-03-15 | Ryan Jason (Chief Financial Officer) | Option Ex | 15,000 | 29.63 | 444,450 |
| 2018-03-15 | Pellini Michael J (Director) | Sale | 3,500 | 78.29 | 274,015 |
| 2018-02-20 | Miller Vincent A. (Chief Medical Officer) | Sale | 48,819 | 80.94 | 3,889,389 |
| 2018-02-20 | Miller Vincent A. (Chief Medical Officer) | Option Ex | 18,819 | 17.79 | 271,646 |
| 2018-02-15 | Cox Troy (Chief Executive Officer) | Sale | 9,012 | 67.22 | 605,786 |
| 2018-02-15 | Ryan Jason (Chief Financial Officer) | Sale | 15,000 | 67.53 | 1,012,950 |
| 2018-02-15 | Ryan Jason (Chief Financial Officer) | Option Ex | 15,000 | 29.63 | 444,450 |
| 2018-02-15 | Pellini Michael J (Director) | Sale | 17,324 | 67.69 | 1,172,661 |
| 2018-02-13 | Kafka Steven J. (President & COO) | Sale | 29,791 | 61.55 | 1,833,636 |
| 2018-02-07 | Cox Troy (Chief Executive Officer) | Sale | 26,713 | 70.13 | 1,873,382 |
| 2018-02-07 | Kafka Steven J. (President & COO) | Sale | 23,064 | 70.13 | 1,617,478 |
| 2018-01-29 | Miller Vincent A. (Chief Medical Officer) | Sale | 4,400 | 75.00 | 330,000 |
| 2018-01-29 | Miller Vincent A. (Chief Medical Officer) | Option Ex | 4,400 | 4.16 | 18,304 |
| 2018-01-22 | Miller Vincent A. (Chief Medical Officer) | Sale | 17,187 | 70.27 | 1,207,730 |
| 2018-01-22 | Miller Vincent A. (Chief Medical Officer) | Option Ex | 17,187 | .84 | 14,437 |
| 2018-01-17 | Miller Vincent A. (Chief Medical Officer) | Sale | 5,534 | 65.39 | 361,868 |
| 2018-01-17 | Miller Vincent A. (Chief Medical Officer) | Option Ex | 5,534 | .84 | 4,648 |
| 2018-01-17 | Pellini Michael J (Director) | Sale | 10,150 | 65.52 | 665,028 |
| 2018-01-16 | Hesslein Robert W. (SVP and General Counsel) | Sale | 18,021 | 64.30 | 1,158,750 |
| 2018-01-16 | Ryan Jason (Chief Financial Officer) | Sale | 21,035 | 64.38 | 1,354,233 |
| 2018-01-16 | Ryan Jason (Chief Financial Officer) | Option Ex | 20,000 | 29.63 | 592,600 |
| 2018-01-16 | Kafka Steven J. (President & COO) | Sale | 4,148 | 65.71 | 272,565 |
| 2018-01-16 | Miller Vincent A. (Chief Medical Officer) | Sale | 9,221 | 65.26 | 601,762 |
| 2018-01-16 | Miller Vincent A. (Chief Medical Officer) | Option Ex | 5,408 | .84 | 4,542 |
| 2018-01-16 | Pellini Michael J (Director) | Sale | 27,138 | 64.19 | 1,741,988 |
| 2018-01-03 | Kafka Steven J. (President & COO) | Sale | 2,257 | 64.00 | 144,448 |
| 2018-01-02 | Nallicheri Melanie (Chief Business Officer) | Sale | 1,494 | 64.00 | 95,616 |
| 2018-01-02 | Hesslein Robert W. (SVP and General Counsel) | Sale | 1,864 | 64.00 | 119,296 |
| 2018-01-02 | Ryan Jason (Chief Financial Officer) | Sale | 2,336 | 64.00 | 149,504 |
| 2018-01-02 | Kafka Steven J. (President & COO) | Sale | 157 | 64.00 | 10,048 |
| 2018-01-02 | Miller Vincent A. (Chief Medical Officer) | Sale | 2,349 | 64.00 | 150,336 |
| 2017-12-13 | Pellini Michael J (Director) | Sale | 48,746 | 61.71 | 3,008,115 |
| 2017-12-13 | Jones Evan/ Fa (Director) | Sale | 1,400 | 62.05 | 86,870 |
| 2017-12-06 | Kafka Steven J. (President & COO) | Sale | 5,774 | 58.57 | 338,183 |
| 2017-12-06 | Kafka Steven J. (President & COO) | Option Ex | 5,774 | 4.16 | 24,019 |
| 2017-12-06 | Pellini Michael J (Director) | Sale | 20,947 | 58.11 | 1,217,230 |
| 2017-12-06 | Jones Evan/ Fa (Director) | Sale | 600 | 57.88 | 34,728 |
| 2017-12-05 | Ryan Jason (Chief Financial Officer) | Sale | 21,726 | 61.26 | 1,330,934 |
| 2017-12-05 | Ryan Jason (Chief Financial Officer) | Option Ex | 21,726 | 3.60 | 78,213 |
| 2017-12-05 | Miller Vincent A. (Chief Medical Officer) | Sale | 20,000 | 61.17 | 1,223,400 |
| 2017-12-05 | Pellini Michael J (Director) | Sale | 9,053 | 61.47 | 556,487 |
| 2017-12-05 | Jones Evan/ Fa (Director) | Sale | 5,900 | 60.94 | 359,546 |
| 2017-11-02 | Ryan Jason (Chief Financial Officer) | Sale | 9,731 | 50.00 | 486,550 |
| 2017-10-13 | Kafka Steven J. (President & COO) | Sale | 3,361 | 44.62 | 149,967 |
| 2017-10-12 | Ryan Jason (Chief Financial Officer) | Sale | 1,152 | 45.05 | 51,897 |
| 2017-10-02 | Nallicheri Melanie (Chief Business Officer) | Sale | 5,440 | 38.80 | 211,071 |
| 2017-10-02 | Hesslein Robert W. (SVP and General Counsel) | Sale | 2,165 | 38.80 | 84,002 |
| 2017-10-02 | Ryan Jason (Chief Financial Officer) | Sale | 3,154 | 38.80 | 122,375 |
| 2017-10-02 | Kafka Steven J. (President & COO) | Sale | 3,201 | 38.80 | 124,198 |
| 2017-10-02 | Miller Vincent A. (Chief Medical Officer) | Sale | 2,944 | 38.80 | 114,227 |
| 2017-10-02 | Pellini Michael J (Director) | Sale | 4,349 | 38.80 | 168,741 |
| 2017-08-09 | Pellini Michael J (Director) | Sale | 30,000 | 39.52 | 1,185,600 |
| 2017-08-09 | Daly David (Chief Commercial Officer) | Sale | 46,872 | 39.50 | 1,851,444 |
| 2017-08-09 | Daly David (Chief Commercial Officer) | Option Ex | 46,872 | 22.24 | 1,042,433 |
| 2017-08-08 | Yeshwant Krishna (Director) | Sale | 4,800 | 40.01 | 192,048 |
| 2017-08-04 | Yeshwant Krishna (Director) | Sale | 18,072 | 36.85 | 665,953 |
| 2017-08-04 | Yeshwant Krishna (Director) | Option Ex | 13,385 | 24.21 | 324,050 |
| 2017-07-14 | Kafka Steven J. (President & COO) | Sale | 11,781 | 39.15 | 461,226 |
| 2017-07-13 | Ryan Jason (Chief Financial Officer) | Sale | 5,084 | 39.77 | 202,190 |
| 2017-07-06 | Hesslein Robert W. (SVP and General Counsel) | Sale | 5,070 | 38.84 | 196,918 |
| 2017-07-06 | Ryan Jason (Chief Financial Officer) | Sale | 6,683 | 38.84 | 259,567 |
| 2017-07-06 | Kafka Steven J. (President & COO) | Sale | 7,398 | 38.84 | 287,338 |
| 2017-07-06 | Miller Vincent A. (Chief Medical Officer) | Sale | 5,408 | 38.84 | 210,046 |
| 2017-07-06 | Pellini Michael J (Director) | Sale | 15,856 | 38.84 | 615,847 |
| 2017-07-06 | Daly David (Chief Commercial Officer) | Sale | 6,316 | 38.84 | 245,313 |
| 2017-07-05 | Kafka Steven J. (President & COO) | Sale | 12,310 | 38.98 | 479,843 |
| 2017-06-08 | Hesslein Robert W. (SVP and General Counsel) | Option Ex | 7,033 | 5.64 | 39,666 |
| 2017-06-02 | Ryan Jason (Chief Financial Officer) | Sale | 5,573 | 40.00 | 222,920 |
| 2017-06-01 | Daly David (Chief Commercial Officer) | Sale | 555 | 38.30 | 21,256 |
| 2017-05-12 | Hesslein Robert W. (SVP and General Counsel) | Sale | 1,009 | 33.87 | 34,174 |
| 2017-04-18 | Ryan Jason (Chief Financial Officer) | Sale | 503 | 34.55 | 17,378 |
| 2017-04-18 | Kafka Steven J. (President & COO) | Sale | 4,405 | 34.55 | 152,192 |
| 2017-04-03 | Hesslein Robert W. (SVP and General Counsel) | Sale | 1,233 | 31.96 | 39,406 |
| 2017-04-03 | Ryan Jason (Chief Financial Officer) | Sale | 1,233 | 31.96 | 39,406 |
| 2017-04-03 | Kafka Steven J. (President & COO) | Sale | 2,157 | 31.96 | 68,937 |
| 2017-04-03 | Miller Vincent A. (Chief Medical Officer) | Sale | 1,353 | 31.96 | 43,241 |
| 2017-04-03 | Pellini Michael J (Director) | Sale | 1,700 | 31.96 | 54,332 |
| 2017-04-03 | Daly David (Chief Commercial Officer) | Sale | 2,070 | 31.96 | 66,157 |
| 2017-03-16 | Hesslein Robert W. (SVP and General Counsel) | Sale | 6,231 | 31.67 | 197,335 |
| 2017-03-16 | Ryan Jason (Chief Financial Officer) | Sale | 12,500 | 31.68 | 396,000 |
| 2017-03-16 | Ryan Jason (Chief Financial Officer) | Option Ex | 12,500 | 2.50 | 31,250 |
| 2017-03-08 | Pellini Michael J (Director) | Sale | 9,489 | 34.28 | 325,282 |
| 2017-03-08 | Pellini Michael J (Director) | Option Ex | 9,489 | 7.12 | 67,561 |
| 2017-03-07 | Pellini Michael J (Director) | Sale | 30,511 | 34.31 | 1,046,832 |
| 2017-03-07 | Pellini Michael J (Director) | Option Ex | 30,511 | 7.12 | 217,238 |
| 2017-03-01 | Daly David (Chief Commercial Officer) | Sale | 541 | 25.12 | 13,589 |
| 2017-02-08 | Kafka Steven J. (President & COO) | Sale | 10,415 | 23.24 | 242,044 |
| 2017-01-13 | Ryan Jason (Chief Financial Officer) | Sale | 1,777 | 19.00 | 33,763 |
| 2017-01-04 | Hesslein Robert W. (SVP and General Counsel) | Sale | 1,426 | 18.49 | 26,366 |
| 2017-01-04 | Ryan Jason (Chief Financial Officer) | Sale | 1,426 | 18.49 | 26,366 |
| 2017-01-04 | Kafka Steven J. (President & COO) | Sale | 2,376 | 18.49 | 43,932 |
| 2017-01-04 | Miller Vincent A. (Chief Medical Officer) | Sale | 1,267 | 18.49 | 23,426 |
| 2017-01-04 | Pellini Michael J (Chief Executive Officer) | Sale | 3,491 | 18.49 | 64,548 |
| 2017-01-04 | Daly David (Chief Commercial Officer) | Sale | 2,370 | 18.49 | 43,821 |
| 2017-01-03 | Hesslein Robert W. (SVP and General Counsel) | Sale | 3,256 | 17.41 | 56,686 |
| 2017-01-03 | Ryan Jason (Chief Financial Officer) | Sale | 3,239 | 17.41 | 56,390 |
| 2017-01-03 | Kafka Steven J. (President & COO) | Sale | 6,014 | 17.41 | 104,703 |
| 2017-01-03 | Miller Vincent A. (Chief Medical Officer) | Sale | 3,506 | 17.41 | 61,039 |
| 2017-01-03 | Pellini Michael J (Chief Executive Officer) | Sale | 11,146 | 17.41 | 194,051 |
| 2017-01-03 | Daly David (Chief Commercial Officer) | Sale | 2,727 | 17.41 | 47,477 |
| 2016-11-22 | Kafka Steven J. (President & COO) | Sale | 4,814 | 23.00 | 110,722 |
| 2016-11-22 | Kafka Steven J. (President & COO) | Option Ex | 4,814 | 4.16 | 20,026 |
| 2016-11-18 | Kafka Steven J. (President & COO) | Sale | 1,459 | 23.06 | 33,644 |
| 2016-11-18 | Kafka Steven J. (President & COO) | Option Ex | 1,459 | 4.16 | 6,069 |
| 2016-11-16 | Kafka Steven J. (President & COO) | Sale | 1,000 | 23.00 | 23,000 |
| 2016-11-16 | Kafka Steven J. (President & COO) | Option Ex | 1,000 | 4.16 | 4,160 |
| 2016-10-20 | Ryan Jason (Chief Financial Officer) | Sale | 506 | 22.45 | 11,359 |
| 2016-10-20 | Kafka Steven J. (President & COO) | Sale | 4,427 | 23.00 | 101,821 |
| 2016-10-04 | Hesslein Robert W. (SVP and General Counsel) | Sale | 1,220 | 23.65 | 28,853 |
| 2016-10-04 | Ryan Jason (Chief Financial Officer) | Sale | 1,220 | 23.65 | 28,853 |
| 2016-10-04 | Kafka Steven J. (President & COO) | Sale | 2,032 | 23.65 | 48,056 |
| 2016-10-04 | Miller Vincent A. (Chief Medical Officer) | Sale | 1,084 | 23.65 | 25,636 |
| 2016-10-04 | Pellini Michael J (Chief Executive Officer) | Sale | 2,629 | 23.65 | 62,175 |
| 2016-10-04 | Daly David (Chief Commercial Officer) | Sale | 2,045 | 23.65 | 48,364 |
| 2016-10-03 | Kafka Steven J. (President & COO) | Sale | 103 | 23.04 | 2,373 |
| 2016-10-03 | Miller Vincent A. (Chief Medical Officer) | Sale | 258 | 23.04 | 5,944 |
| 2016-09-20 | Kafka Steven J. (President & COO) | Sale | 9,469 | 23.70 | 224,415 |
| 2016-09-20 | Kafka Steven J. (President & COO) | Option Ex | 7,850 | 4.16 | 32,656 |
| 2016-09-01 | Daly David (Chief Commercial Officer) | Sale | 551 | 20.48 | 11,284 |
| 2016-08-19 | Ryan Jason (Chief Financial Officer) | Sale | 13,863 | 23.93 | 331,672 |
| 2016-08-19 | Ryan Jason (Chief Financial Officer) | Option Ex | 5,000 | 7.12 | 35,600 |
| 2016-08-09 | Hesslein Robert W. (SVP and General Counsel) | Option Ex | 9,377 | 5.64 | 52,886 |
Insider trading activities including stock purchases, stock sales, and option exercises of FMI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Foundation Medicine, Inc. (symbol FMI, CIK number 1488613) see the Securities and Exchange Commission (SEC) website.